Prospects for the future of prostate cancer vaccines

Ravi A Madan1, James L Gulley1

  • 1a Genitourinary Malignancies Branch , National Cancer Institute , Bethesda , MD , USA.

Expert Review of Vaccines
|November 13, 2015
PubMed

Insights

Cancer vaccines, particularly in prostate cancer, are emerging as a key immunotherapy. Despite current focus on immune checkpoint inhibitors, vaccines show potential to enhance anti-tumor capabilities and clinical outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Cancer therapy is rapidly evolving with a focus on harnessing the immune system's anti-tumor potential.
  • Immune checkpoint inhibitors are currently prominent, especially in melanoma, lung, and bladder cancers.
  • Early successes in prostate cancer demonstrated that therapeutic cancer vaccines could improve outcomes.

Purpose of the Study:

  • To evaluate the evolving role of cancer vaccines in prostate cancer therapy.
  • To highlight the therapeutic potential of cancer vaccines within the broader field of immunotherapy.
  • To underscore the significance of emerging data on vaccine efficacy.

Main Methods:

  • Review of clinical data on cancer immunotherapy.
  • Analysis of the impact of therapeutic cancer vaccines.
  • Assessment of the current landscape of prostate cancer treatment.

Main Results:

  • Clinical data confirm the immune system's significant anti-tumor capabilities.
  • Therapeutic cancer vaccines in prostate cancer were pioneers in demonstrating immunotherapy's clinical benefits.
  • Emerging data suggest a crucial therapeutic role for vaccines in prostate cancer.

Conclusions:

  • Cancer vaccines are a vital component of immunotherapy, with significant potential in prostate cancer.
  • While immune checkpoint inhibitors dominate current focus, vaccines offer a complementary or alternative strategy.
  • Further research and clinical application of cancer vaccines are warranted for improved patient outcomes.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K